Shenyang Northern Hospital
Clinical trials sponsored by Shenyang Northern Hospital, explained in plain language.
-
Heart attack patients: new study aims to personalize blood thinner timing
Disease control Recruiting nowThis study tests whether a simple risk score (OPT-CAD) can guide doctors on when to safely switch heart attack patients from two blood thinners to just one. About 3,500 participants will be assigned to stop one blood thinner at either 1 or 3 months based on their risk level. The …
Phase: NA • Sponsor: Shenyang Northern Hospital • Aim: Disease control
Last updated May 17, 2026 11:58 UTC
-
AI app could save heart attack patients when quick surgery isn't possible
Disease control Recruiting nowThis study tests whether an artificial intelligence mobile app can help doctors give clot-busting medicine earlier to people having a severe heart attack (STEMI) when they can't get a stent placed within 2 hours. About 3,356 adults will be enrolled across multiple hospitals in Ch…
Phase: NA • Sponsor: Shenyang Northern Hospital • Aim: Disease control
Last updated May 14, 2026 12:05 UTC
-
10,000 heart patients enrolled in landmark study to uncover best treatments
Knowledge-focused Recruiting nowThis study follows 10,000 adults hospitalized with confirmed or suspected coronary heart disease. Researchers will collect detailed health data and track heart attacks, strokes, and deaths over time. The goal is to see which real-world treatments work best, so doctors can persona…
Sponsor: Shenyang Northern Hospital • Aim: Knowledge-focused
Last updated May 17, 2026 12:01 UTC